ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.64
0.22%
US Tech 100
20,340.80
0.54%
S&P 500
5,969.34
0.35%
US Dollar vs CAD
1.39598
-0.15%
Bitcoin
98,628.29
0.59%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Ab Science (AB) Share Price

Ab Science

Ab Science (AB)

AllianceBernstein Holding LP
0.799
-0.001
( -0.13% )
Updated: 03:34:18
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
0.799
Bid
0.79
Ask
0.798
Volume
5,876
0.79 Day's Range 0.80
0.79 52 Week Range 4.465
Market Cap
41.605M
Previous Close
0.80
Open
0.79
Last Trade
1
@
0.799
Last Trade Time
02:59:03
Financial Volume
-
VWAP
-
Average Volume (3m)
36,173
Shares Outstanding
52,071,069
Dividend Yield
-
PE Ratio
-3.48
Earnings Per Share (EPS)
-0.23
Revenue
970k
Net Profit
-11.99M

About Ab Science

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.ab-science.com
Headquarters
Paris, Paris, Fra
Founded
-
Ab Science is listed in the Pharmaceutical Preparations sector of the Euronext with ticker AB. The last closing price for Ab Science was 0.80 €. Over the last year, Ab Science shares have traded in a share price range of 0.79 € to 4.465 €.

Ab Science currently has 52,071,069 shares outstanding. The market capitalization of Ab Science is 41.66 € million. Ab Science has a price to earnings ratio (PE ratio) of -3.48.

Ask ADVFN Intelligence (AI)

AB Latest News

More News

AB Science receives notice of allowance for European patent covering masitinib until 2040 in the treatment of sickle cell disease

AB Science receives notice of allowance for European patent covering masitinib until 2040 in the treatment of sickle cell disease PRESS RELEASE AB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR EUROPEAN...

October 28 2024
UK Regulatory

AB Science reçoit un avis d’acceptation pour le brevet européen couvrant jusqu’en 2040 le masitinib dans le traitement de la drépanocytose

AB Science reçoit un avis d’acceptation pour le brevet européen couvrant jusqu’en 2040 le masitinib dans le traitement de la drépanocytose COMMUNIQUE DE PRESSE AB SCIENCE REÇOIT UN AVIS...

October 28 2024
UK Regulatory

AB Science receives notice of allowance for European patent covering masitinib until 2040 in the treatment of sickle cell disease

PRESS RELEASE AB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR EUROPEAN PATENT COVERING MASITINIB UNTIL 2040 IN THE TREATMENT OF SICKLE CELL DISEASE THIS DECISION FURTHER STRENGTHENS MASITINIB’S...

October 28 2024
GlobeNewswire Inc.

AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS

AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON THE APPLICATION FOR CONDITIONAL...

October 17 2024
UK Regulatory

AB Science fait le point sur la demande d'autorisation de mise sur le marché conditionnelle du masitinib dans la SLA

AB Science fait le point sur la demande d'autorisation de mise sur le marché conditionnelle du masitinib dans la SLA COMMUNIQUE DE PRESSE AB SCIENCE FAIT LE POINT SUR LA DEMANDE...

October 17 2024
UK Regulatory

AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS

PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON THE APPLICATION FOR CONDITIONAL MARKETING AUTHORISATION OF MASITINIB IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS Paris, 17 October, 2024...

October 17 2024
GlobeNewswire Inc.

AB Science : Résultats financiers semestriels au 30 juin 2024 et point sur les activités d’AB Science

AB Science : Résultats financiers semestriels au 30 juin 2024 et point sur les activités d’AB Science          COMMUNIQUE DE PRESSE AB SCIENCE PRÉSENTE SES RÉSULTATS FINANCIERS AU PREMIER SEMESTRE...

October 10 2024
UK Regulatory

AB Science: Revenues for the first half of 2024 and update on AB Science’s activities

AB Science: Revenues for the first half of 2024 and update on AB Science’s activities          PRESS RELEASE AB SCIENCE PRESENTS ITS FINANCIAL RESULTS FOR THE FIRST HALF OF 2024 AND THE KEY EVENTS...

October 10 2024
UK Regulatory

AB Science: Revenues for the first half of 2024 and update on AB Science’s activities

         PRESS RELEASE AB SCIENCE PRESENTS ITS FINANCIAL RESULTS FOR THE FIRST HALF OF 2024 AND THE KEY EVENTS OF THE PERIOD Clinical development Masitinib platform: Ongoing re-examination by...

October 10 2024
GlobeNewswire Inc.

AB Science annonce avoir réalisé le règlement livraison de sa dernière augmentation de capital de 5,0 millions d’euros

AB Science annonce avoir réalisé le règlement livraison de sa dernière augmentation de capital de 5,0 millions d’euros COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE AVOIR REALISE LE REGLEMENT LIVRAISON...

October 09 2024
UK Regulatory
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.086-9.717514124290.8850.890.79657790.82608986DE
4-0.167-17.28778467910.9661.050.79464400.91238887DE
12-0.251-23.90476190481.051.0660.79361730.96177527DE
26-1.286-61.67865707432.0852.1550.79704761.21972209DE
52-2.021-71.66666666672.824.4650.79997432.21709468DE
156-11.631-93.57200321812.4313.340.79955024.68102052DE
260-4.241-84.14682539685.0421.750.791448408.45773046DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALCYBCybergun
0.0002 €
(100.00%)
2.71M
ATOAtos SE
0.232 €
(48.72%)
5.64M
ALARFAdeunis
0.79 €
(21.91%)
2.68k
ALCBXCibox Interactive
0.0444 €
(20.00%)
4.06M
ALGTRGroupe Tera SA
2.08 €
(14.29%)
120
BIDSGascogne DS
0.0024 €
(-52.00%)
8.78k
ALMASMastrad
0.0104 €
(-13.33%)
887.88k
ALBDMBD Multi-Media
1.14 €
(-11.97%)
204
ALGAUGaussin
0.0373 €
(-10.77%)
150.13k
ALEMSEuropean Medical Solutions
0.017 €
(-10.53%)
3.5k
BCPBanco Comercial Portugues SA
0.4487 €
(0.92%)
16.17M
ALNEVNeovacs
0.0002 €
(0.00%)
9.5M
ALTDTonner Drones
0.0106 €
(6.00%)
8.75M
ATOAtos SE
0.232 €
(48.72%)
5.64M
ALHPIHopium SA
0.0099 €
(4.21%)
4.86M

Discussion

View Full Feed
Not a Real Company Not a Real Company 2 minutes ago
Larry,



The latest issue of Investors Business Daily features a company called American Superconductor. AMSC is the ticker. From IBD:



AMSC provides megawatt-scale power control gear. Its solutions are designed to improve energy efficienc
AMSC
sefdry00052 sefdry00052 2 minutes ago
We can assist you in securing +1-888-848-2409 your SBC GLOBAL emails by enabling advanced security features such as two-factor authentication and SSL encryption.
gregcod gregcod 4 minutes ago
Well, holidays are here...I wish we had a drone shot or sattelite shots of the IBAT plant in UTAH..if it still is at the US Mag site..who knows for sure..all is quiet as a mouse..but IMO, some good news coming but when?..
IBATF
SunnySage38 SunnySage38 4 minutes ago
https://support.google.com/phoneapp/thread/309707689?hl=en&sjid=10046605087460782461-NA

https://support.google.com/phoneapp/thread/309707689?hl=en&sjid=10046605087460782461-NA

https://support.google.com/phoneapp/thread/309707689?hl=en&sjid=10046605087460782461-NA
sefdry00052 sefdry00052 5 minutes ago
Technical support to fix every kind of error in your SBC GLOBAL account:
We can help fix any kind of error that may arise in your SBC GLOBAL account, such as login issues, sending or receiving emails, or any other technical issue.
Organize and plan single/multiple SBC GLOBAL accounts:
SwissCheeseAccount SwissCheeseAccount 6 minutes ago
"fel·low/'felo/
noun
a man or boy.
a person in the same position, involved in the same activity, or otherwise associated with another.
a member of a learned society.

I think this describes all of us here 🤣
LEHNQ
Bull_Dolphin Bull_Dolphin 8 minutes ago
Good deal for him.... $36K bonus for gunning down Ashli

https://www.oann.com/video/oan-contribution/ashli-babbitts-killers-troubled-career/
SwissCheeseAccount SwissCheeseAccount 10 minutes ago
Come on side it says it right there! 😆

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=168185449

08-13555-scc Doc 59859 -1 Filed 08/02/19 Entered 08/02/19 15:15:59 Exhibit A
Pg 87 of 112

https://dm.epiq11.com/case/lehman/d
LEHNQ
P-Rawl P-Rawl 12 minutes ago
Thanks. That's really helpful. Lots of posts saying Jake anticipates something-or-other in the next few days or weeks, so lets hope at least some of them eventually happen. It's Monday 25th now so Mark should finally provide some good news by the end of the day. Does anyone know who Mark is and who
BCAP
nowwhat2 nowwhat2 16 minutes ago
The Big (Not So) Big Question ;


https://investorshub.advfn.com/uimage/uploads/2024/11/25/hgzjxbtc_111111_25_5d_1am_100000_PUMP_Q.jpg



https://investorshub.advfn.com/uimage/uploads/2024/11/25/emioibtc_111111_25_5d_130am_100000_BOOM.jpg
XRPUSD
Bull_Dolphin Bull_Dolphin 17 minutes ago
3 old farts make a good bit of music:

https://rumble.com/v5rvmm8-cant-you-see..html?e9s=src_v1_leaderboard
B_B! B_B! 19 minutes ago
Finally heading towards $6.


‘Wicked’ Breaks Records as Box Office Soars to $270M Weekend
This weekend, two high-profile films spurred renewed confidence for the film business, grossing $270.2 million worldwide and posting the best pre-Thanksgiving box office performance
AMC
MarauderRealm57 MarauderRealm57 19 minutes ago
https://support.google.com/phoneapp/thread/309706881?hl=en&sjid=17540613889746558025-AP
https://support.google.com/phoneapp/thread/309706881?hl=en&sjid=17540613889746558025-APhttps://support.google.com/phoneapp/thread/309706881?hl=en&sjid=17540613889746558025-AP
https://support.google.
aBeezlee aBeezlee 19 minutes ago
Tesla and Nvidia were small names that caught many off guard. Rocket could very well be another name that sees exponential growth in a decade. Peter seems determined to compete in the space race, and I don't doubt his commitment for a second. Just wish I had a genie to spawn more money for me.!
RKLB
Investor2014 Investor2014 22 minutes ago
Who many of those catalysts do you expect to be able to tick off before year end?
AVXL
Investor2014 Investor2014 23 minutes ago
It may seem counterintuitive to some, but not to the market and knowledgeable biotech investors who can see past the rosy PR wording and context free impressive looking data point snippets.
AVXL
Bull_Dolphin Bull_Dolphin 25 minutes ago
Top Bot:

https://rumble.com/v5srbmh-elon-musk-meanwhile-some-idiots-are-still-building-manned-fighter-jets-....html?e9s=src_v1_upp
Bull_Dolphin Bull_Dolphin 31 minutes ago
Nothing here but us chickens:

https://redstate.com/jeffc/2024/11/23/texas-farmer-faces-20-years-in-prison-after-armed-agents-raid-her-home-over-chicken-eggs-n2182378#google_vignette
Diamondhands45 Diamondhands45 31 minutes ago
And that's all you got?  The day to day price movement in an overall bearish OTC market?  

Explain why you are always wrong
SPZI
knrorrel knrorrel 32 minutes ago
$QBTS looks great , here reading 🥳 wow D. Trump and many more https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175435522

QBTS

Your Recent History

EU
AB
Ab Science
TSXV
AT
AcuityAds
DBI
XEGB
DAXplus Minimum Variance...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved